Jeffrey W. Runge

Jeffrey W. Runge, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Altimmune, Inc., Aditxt, Inc. and Pace Health Management Systems Inc. Between 17 June 2011 and 1 June 2021, the trades on record add up to 18 filings.

The open-market record is one-sided, with 8 purchases worth €77k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 9 option exercises. In 2021 alone, the filings show 6 purchases and no sales.

Half of the purchases are above €4,796 and half below. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -36.9%. These figures describe past trades and do not predict future prices.

Most recently, on 2 June 2021, the filings show an open-market purchase worth €4,796 in Aditxt, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.